inSoma Bio is a biopharma and biotechnology startup, headquartered in the United States, founded in 2018. The company's slogan, "Rebuilding you with you," exemplifies their innovative approach towards reconstructive plastic surgery. They specialize in leveraging nature’s own designs to develop unique products, with a prime focus on reconstructive plastic surgery. Their investigational Fractomer™️ product, based on technology originating from Duke University, sets them apart in the industry. This product enables surgeons to use a person’s own tissue, eliminating the need for synthetic implants and fillers in procedures like breast and facial reconstruction. In June 2024, inSoma Bio successfully secured Seed Round investment from CAV Angels, marking a significant milestone in their journey. This funding is poised to propel their research and product development, further contributing to the advancements in reconstructive plastic surgery. With its promising approach and strategic partnerships, inSoma Bio is positioned to make a notable impact in the healthcare industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | Unknown | 1 | CAV Angels | 12 Jun 2024 |
Seed Round | $2.72M | - | 01 May 2023 | |
Debt Financing | $500.00K | 1 | North Carolina Biotechnology Center | 16 Feb 2023 |
Grant | $75.00K | 1 | One North Carolina Small Business Program | 22 Sep 2022 |
Pre Seed Round | $1.80M | 1 | 01 Jan 2022 |
No recent news or press coverage available for inSoma Bio.